The first ready-to-show mouthpiece was finished, and a month later in June 2017 the mouthpiece was first exhibited at the American Society of Clinical Oncology (ASCO) Annual Meeting. The product was so well received, David knew this idea deserved even more focus.
For the next year or so, David and his team would spend incalculable hours and efforts in finalizing this device, as they knew it was about to be a huge sensation for the oncology community. They were about to bring something to market that would be such a huge benefit for cancer patients going through treatment. They would participate in tradeshows to get even more feedback from the oncology community in order to better their product.